Big Gain For Novavax, Inc.
Tue, Dec 07, 2021 at 05:30 PM
Novavax, Inc. (NVAX:NASDAQ) soared at $182.85, a gain of 28.9%. On Mon, Dec 06, 2021, NVAX:NASDAQ touched a New 2-Week Low of $141.86. The stock appeared on our News Catalysts scanner on Tue, Dec 07, 2021 at 05:20 PM in the 'MISCELLANEOUS' category. From Mon, Nov 22, 2021, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Mon, Nov 29, 2021 at $229 with a volume of 10M+.
About Novavax, Inc. (NVAX:NASDAQ)
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Top 10 Gainers:
- ENSC (ENSC:NASDAQ), 136.3%
- SYTA (SYTA:NASDAQ), 66.67%
- Trupanion, Inc. (TRUP:NASDAQ), 39.03%
- Jianpu Technology Inc. (JT:NYSE), 37.94%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 35.29%
- TESSCO Technologies Incorporated (TESS:NASDAQ), 30.95%
- Secoo Holding Limited (SECO:NASDAQ), 29.87%
- Novavax, Inc. (NVAX:NASDAQ), 28.89%
- TIRX (TIRX:NASDAQ), 25.14%
- VAXX (VAXX:NASDAQ), 24.45%